Prostate Cancer Screening Updates and PSA Risk Strategies
Modern prostate cancer screening uses risk-adapted PSA and MRI.
Read More
Localized/Locally Advanced
Testosterone and Prostate Cancer: From Dogma to Data
Helen L. Bernie, DO, MPH, reviews evidence on testosterone therapy and prostate cancer risk and management.
Read More
MTI in Biochemical Recurrent Disease: What Threshold, Which Images?
PSMA PET guides treatment planning in biochemical recurrence but should not delay early salvage therapy.
Read More
Selection and Management for Locally Advanced Disease Declining Clinical Trials
Evidence shows similar survival outcomes between surgery and radiation when guideline-based therapy is applied.
Read More
Rethinking Focal Therapy: Whole-Gland Ablation for Select Patients
Dr. Abhinav Sidana examines when whole-gland ablation may be preferable to focal therapy for selected prostate cancer patients.
Read More